Content overview
Compliance – standards that guide us
Bioethical principles
Supplier management
Security, Risk & Compliance
Content
- Compliance – standards that guide us
- Bioethical principles
- Supplier management
- Security, Risk & Compliance
We believe that doing science responsibly starts with doing business responsibly. That means staying true to our values – acting with integrity, treating people fairly, and respecting human rights in everything we do. Our approach to governance helps us make thoughtful decisions, stay accountable, and build trust across our teams and with our partners.
Content overview
Compliance – standards that guide us
Bioethical principles
Supplier management
Security, Risk & Compliance
Our corporate governance policies set clear expectations for how we work. They define our ethical standards, guide compliance, and reflect our commitment to responsible business practices wherever we operate.
We uphold a strict zero-tolerance policy toward all forms of corruption, including bribery, fraud, and extortion. Our global anti-corruption policy applies to all employees, directors, contractors, and agents.
Core principles include:
Any violation of this policy may lead to disciplinary action and legal consequences. Through these measures, we protect our integrity, reputation, and shared values at every level of our organization.
At Miltenyi Biotec, we see the immense potential of human pluripotent stem cells, especially induced pluripotent stem cells (iPSCs), to drive progress in regenerative medicine, drug development, and disease modeling.
We promote the ethical and responsible use of these cells by applying advanced technologies and working closely with the scientific community. While basic research involving human embryonic stem cells (ESCs) is conducted under strict ethical and legal oversight, our primary focus is on iPSCs, which are derived from adult cells such as blood or skin. This approach enables scientific progress while ensuring full donor consent.
Miltenyi Biotec supports the scientific community with tools and platforms for stem cell research. While we do not use human stem cells in therapies ourselves, we provide enabling technologies to support those who do.
Areas of support:
Miltenyi Biotec integrates sustainability into procurement practices to support long-term value creation, regulatory alignment, and shared progress. Drawing on internationally recognized frameworks such as the International Labour Organization (ILO), the German Supply Chain Due Diligence Act (LkSG), and the EU Corporate Sustainability Reporting Directive (CSRD), we aim to foster a resilient and responsible supply chain aligned with our prioritized Sustainable Development Goals (SDGs).
We are forward-thinking and contribute to a healthier future.
We stand for equality across genders, as well as for the empowerment of women.
We support equal access to education and enable life-long learning.
We believe that sustainability and innovation go hand-in-hand.
We make a meaningful, lasting impact in the communities in which we operate.
Through ongoing monitoring, assessment, and disclosure of relevant sustainability data, we seek to identify and address risks early, enhance transparency, and promote accountability across our supplier network.
Our supplier code of conduct outlines the ethical, social, and environmental standards we expect from all partners. It is built on key principles, including:
Suppliers are required to uphold these standards not only within their own operations but also across their entire supply chain. Non-compliance may result in corrective actions or, in severe cases, termination of the business relationship.
You can find the code of conduct in our download section.
For over 36 years, the Miltenyi Group has played a key role in advancing biomedical research and enabling cell and gene therapy.
The sensitive nature of biomedical data, including patient related records, research findings, and proprietary technologies, makes us a prime target for cybercriminals.
Ensuring robust information security is not just a technical necessity but a moral imperative. By prioritizing data protection, the Miltenyi Group safeguards patient privacy, protects valuable research, ensures regulatory compliance, mitigates operational risks, and builds public trust.
The Board of Management holds overall accountability for ensuring strong Information Security policies, balancing risks, and compliance needs.
The Chief Information Security Officer manages Information Security for the whole Miltenyi Group with a strong infrastructure.
Our policy framework is in accordance with international standards, such as ISO 27001:2022, ISA/IEC-62443, and NIST 800.
Additionally, we are aligned with the German BSI-Grundschutz to ensure reliable information security.
The framework is subject to continual evaluation and enhancement to ensure compliance with global legal and regulatory requirements.
As we continue to evolve, so does our commitment to
robust and adaptive information security measures.
You have previously chosen International as your location.
What do you want to do?